Approval for modifications to the gambro prisma tpe 2000 set with plasmafilter pf 2000n to permit the use of the plasmafilter with the gambro prismaflex system. The device, as modified, will be marketed under the trade name prismaflex tpe 2000 set and is indicated for therapeutic plasmapheresis.
Device | PRISMAFLEX TPE 2000 SET |
Classification Name | Separator For Therapeutic Purposes, Membrane Automated Blood Cell/plasma |
Generic Name | Separator For Therapeutic Purposes, Membrane Automated Blood Cell/plasma |
Applicant | BAXTER INTERNATIONAL, INC. |
Date Received | 2007-10-09 |
Decision Date | 2011-06-17 |
PMA | P830063 |
Supplement | S006 |
Product Code | MDP |
Advisory Committee | Gastroenterology/Urology |
Supplement Type | Real-time Process |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | BAXTER INTERNATIONAL, INC. 1 Baxter Pkwy. deerfield, IL 60015-4633 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P830063 | | Original Filing |
S024 |
2022-10-18 |
30-day Notice |
S023 |
2022-03-29 |
30-day Notice |
S022 |
2022-03-02 |
30-day Notice |
S021 | | |
S020 |
2021-11-09 |
Real-time Process |
S019 |
2021-05-26 |
30-day Notice |
S018 | | |
S017 |
2020-07-29 |
30-day Notice |
S016 |
2020-03-05 |
Real-time Process |
S015 |
2020-02-24 |
Special (immediate Track) |
S014 |
2019-11-15 |
30-day Notice |
S013 | | |
S012 |
2019-06-27 |
Real-time Process |
S011 | | |
S010 |
2017-10-26 |
30-day Notice |
S009 |
2016-12-02 |
30-day Notice |
S008 |
2015-10-13 |
Special (immediate Track) |
S007 |
2015-05-29 |
30-day Notice |
S006 |
2007-10-09 |
Real-time Process |
S005 |
2006-11-24 |
Normal 180 Day Track |
S004 |
2001-11-13 |
Normal 180 Day Track |
S003 |
2000-10-31 |
Real-time Process |
S002 |
2000-01-18 |
Normal 180 Day Track |
S001 |
1995-07-06 |
Normal 180 Day Track |
NIH GUDID Devices